Clinical Trials Logo

Elderly Infection clinical trials

View clinical trials related to Elderly Infection.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05825651 Recruiting - COVID-19 Pandemic Clinical Trials

Long COVID and Its Associations With Health Outcomes in Older Adults

Start date: April 24, 2023
Phase:
Study type: Observational

The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohort study carried out in Anning, Yunnan. The primary aim of this study is to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.

NCT ID: NCT04978116 Recruiting - Pneumonia Clinical Trials

CT Scan Compared to CXR and LUS in Pneumonia in the Elderly

OCTOPLUS
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Introduction: Pneumonia is a leading cause of mortality and a common indication for antibiotic in elderly patients. However, its diagnosis is often inaccurate. We aim to compare the diagnostic accuracy, the clinical and cost outcomes and the use of antibiotics associated with three imaging strategies in patients >65 years old with suspected pneumonia in the emergency room (ER): Chest-X ray (CXR, standard of care), low-dose CT scan (LDCT) or lung US (LUS). Methods and analysis: This is a multicenter randomized superiority clinical trial with three parallel arms. Patients will be allocated in the ER to a diagnostic strategy based on either CXR, LDCT, or LUS. All three imaging modalities will be performed but the results of two of them will be masked during 5 days to the patients, the physicians in charge of the patients and the investigators according to random allocation. The primary objective is to compare the accuracy of LDCT vs CXR- based strategies. As secondary objectives, antibiotics prescription, clinical and cost outcomes will be compared, and the same analyses repeated to compare the LUS and CXR strategies. The reference diagnosis will be established a posteriori by a panel of experts. Based on a previous study, we expect an improvement of 16% of the accuracy of pneumonia diagnosis using LDCT instead of CXR. Under this assumption, and accounting for 10% of drop out, the enrolment of 495 patients is needed to prove the superiority of LDCT over CRX (alpha error =0.05, beta error=0.10). Impact of the study: Superiority of the LDCT or LUS strategy over CXR would affect recommendations for the diagnosis of pneumonia in elderly patients. A higher accuracy of one of the strategies may decrease antibiotics overuse and lead to better outcomes and reduced costs.

NCT ID: NCT04799626 Recruiting - Elderly Infection Clinical Trials

Population Pharmacokinetics and Dosage Individualization of Antibiotics in Elderly Patients

Start date: April 1, 2021
Phase:
Study type: Observational [Patient Registry]

The investigator's purpose is to study the pharmacokinetics and pharmacodynamics of biapenem,meropenem,piperacillin and tazobactam,tigecycline,levofloxacin.etc in elderly ICU patients and recommend an individual dosage regimen of those antibiotics.

NCT ID: NCT04436991 Recruiting - Frailty Clinical Trials

Antibiotic Dosing in Geriatric Patients at the Emergency Department

AGED
Start date: January 3, 2018
Phase:
Study type: Observational [Patient Registry]

In this pilot study, we will investigate whether - with the current dosing regimens, used in the Ghent University Hospital - pharmacodynamic targets regarding beta-lactam antibiotics (more specific Amoxicilline-Clavulanate, Piperacillin-Tazobactam and Temocillin) are attained in frail patients admitted to the geriatric department.

NCT ID: NCT03292744 Recruiting - Clinical trials for Frail Elderly Syndrome

Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly

Start date: January 10, 2017
Phase: Phase 4
Study type: Interventional

Vitamin D has been known to influence immune response through Vitamin D Receptor in Immune Cells, but only few has been known about the effect alfacalcidol, a vitamin D analog to immune system. In elderly, immune disregulation or immunosenecence have great impact to infection response. This study is aimed to determine the effect of alfacalcidol supplementation in vitro and in vivo to respiratory infection incidence and inflammatory markers, as well as T cell lymphocyte subset in Indonesian elderly patients.